NATL HEALTH INVESTORS INC (NHI) Stock Analyst Ratings
USA - NYSE:NHI - US63633D1046 - REIT
77.15 USD
+0.3 (+0.39%)
77.15 USD
0 (0%)
ChartMill assigns a Buy % Consensus number of 78% to NHI. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 85.24. This target is 10.49% above the current price.
NHI was analyzed by 11 analysts. The buy percentage consensus is at 78. So analysts seem to be have mildly positive about NHI.
In the previous month the buy percentage consensus was at a similar level.
NHI was analyzed by 11 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-10-01 | Cantor Fitzgerald | Initiate | Overweight |
| 2025-08-27 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-08-15 | Truist Securities | Maintains | Buy -> Buy |
| 2025-07-10 | Keybanc | Upgrade | Sector Weight -> Overweight |
| 2025-06-09 | Truist Securities | Maintains | Hold -> Hold |
| 2025-03-19 | Truist Securities | Maintains | Hold -> Hold |
| 2025-03-17 | Wedbush | Reiterate | Outperform -> Outperform |
| 2024-12-23 | Truist Securities | Maintains | Hold -> Hold |
| 2024-09-24 | B of A Securities | Initiate | Buy |
| 2024-08-30 | Truist Securities | Maintains | Hold -> Hold |
| 2024-06-26 | Truist Securities | Maintains | Hold -> Hold |
| 2024-05-30 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2024-04-04 | Truist Securities | Maintains | Hold -> Hold |
| 2024-03-18 | Wedbush | Maintains | Outperform -> Outperform |
| 2024-03-12 | BMO Capital | Upgrade | Market Perform -> Outperform |
| 2024-02-26 | Wedbush | Upgrade | Neutral -> Outperform |
| 2024-02-26 | Wells Fargo | Upgrade | Equal-Weight -> Overweight |
| 2024-01-30 | Deutsche Bank | Initiate | Buy |
| 2023-11-28 | Stifel | Reiterate | Hold -> Hold |
| 2023-11-27 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2023-10-03 | Wedbush | Initiate | Neutral |
| 2023-09-28 | Berenberg | Initiate | Hold |
| 2023-09-20 | Jefferies | Initiate | Hold |
| 2023-05-11 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2023-03-29 | Credit Suisse | Maintains | Neutral |
| 2022-12-09 | Credit Suisse | Upgrade | Underperform -> Neutral |
| 2022-09-26 | Truist Securities | Maintains | Hold |
| 2022-06-21 | BMO Capital | Downgrade | Outperform -> Market Perform |
| 2022-04-19 | BMO Capital | Maintains | Outperform |
| 2022-02-01 | Credit Suisse | Initiate | Underperform |
NATL HEALTH INVESTORS INC / NHI FAQ
What is the average price target for NATL HEALTH INVESTORS INC (NHI) stock?
11 analysts have analysed NHI and the average price target is 85.24 USD. This implies a price increase of 10.49% is expected in the next year compared to the current price of 77.15.
What is the consensus rating for NATL HEALTH INVESTORS INC (NHI) stock?
The consensus rating for NATL HEALTH INVESTORS INC (NHI) is 78.1818 / 100 . This indicates that analysts generally have a positive outlook on the stock.
How many analysts have analysed NATL HEALTH INVESTORS INC (NHI)?
The number of analysts covering NATL HEALTH INVESTORS INC (NHI) is 11.